Nanoparticles in Infectious Disease Control: Microbial Synthesis, Antimicrobial Mechanisms, and Therapeutic Innovations

Anam Abbas; Saleha Ilyas; Hina Salahuddin; Muhammad Talha Talib; Muhammad Asif; Samavia Mustafa; Ayesha Bint-E-Bilal; Maliha Ghaffar

doi:10.70749/ijbr.v3i6.1466

Authors

Anam Abbas Department of Biology, University of Okara, Pakistan
Saleha Ilyas Veterinary Diagnostics Lab, Lahore, Pakistan
Hina Salahuddin Department of Zoology, University of Okara, Pakistan
Muhammad Talha Talib Department of Clinical Sciences, University of Veterinary and Animal Science, Lahore (Sub-Campus Jhang), Pakistan
Muhammad Asif Shifa College of Medical Technology, Shifa Tameer-e-Millat University Islamabad, Pakistan
Samavia Mustafa Department of Biology, University of Okara, Pakistan
Ayesha Bint-E-Bilal University of Veterinary and Animal Science, Lahore, Pakistan
Maliha Ghaffar Department of Biology, University of Okara, Pakistan

DOI:

https://doi.org/10.70749/ijbr.v3i6.1466

Keywords:

Nanoparticles, Infectious Diseases, Antimicrobial Activity, Microbial Synthesis, Multidrug Resistance, Drug Delivery, Microbiology

Abstract

The escalating threat of multidrug-resistant (MDR) pathogens has underscored the urgent need for innovative strategies to combat infectious diseases. Nanoparticles (NPs) have emerged as a versatile platform due to their unique physicochemical properties and potent antimicrobial capabilities. This review provides an in-depth analysis of NPs in infectious disease management, emphasizing their antimicrobial mechanisms, microbial synthesis, and therapeutic applications. Metal-based NPs, such as silver (AgNPs), zinc oxide (ZnO NPs), and copper oxide (CuO NPs), disrupt microbial cell membranes, generate reactive oxygen species (ROS), and inhibit biofilms, making them effective against bacteria, viruses, fungi, and parasites. Green synthesis using bacteria, fungi, and algae offers a sustainable, biocompatible approach to NP production, enhancing their suitability for medical applications. NPs improve drug delivery, overcome MDR, and support advanced therapies, including wound healing, antiviral treatments, vaccine development, and immunotherapy. This review also explores NP interactions with the microbiome, diagnostic applications, and specific bacterial infectious diseases—such as tuberculosis, pneumonia, urinary tract infections, skin infections, Helicobacter pylori infections, and Clostridium difficile infections along with their NP-based treatments. Challenges like toxicity, scalability, regulatory hurdles, and potential NP resistance are discussed, alongside future directions involving CRISPR and AI-driven NP design.

Downloads

Download data is not yet available.

References

Ventola, C. L. (2015). The antibiotic resistance crisis: Part 1: Causes and threats. Pharmacy and Therapeutics, 40(4), 277–283.

World Health Organization. (2020). Antimicrobial resistance: Global report on surveillance. WHO Press.

Wang, L., Hu, C., & Shao, L. (2017). The antimicrobial activity of nanoparticles: Present situation and prospects for the future. International Journal of Nanomedicine, 12, 1227–1249.

https://doi.org/10.2147/ijn.s121956

Hulkoti, N. I., & Taranath, T. C. (2014). Biosynthesis of nanoparticles using microbes—A review. Colloids and Surfaces B: Biointerfaces, 121, 474–483.

https://doi.org/10.1016/j.colsurfb.2014.05.027

Beyth, N., Houri-Haddad, Y., Domb, A., Khan, W., & Hazan, R. (2015). Alternative antimicrobial approach: Nano-antimicrobial materials. Evidence-Based Complementary and Alternative Medicine, 2015, 1–16.

https://doi.org/10.1155/2015/246012

Sondi, I., & Salopek-Sondi, B. (2004). Silver nanoparticles as antimicrobial agent: A case study on E. coli as a model for Gram-negative bacteria. Journal of Colloid and Interface Science, 275(1), 177–182.

https://doi.org/10.1016/j.jcis.2004.02.012

Dizaj, S. M., Lotfipour, F., Barzegar-Jalali, M., Zarrintan, M. H., & Adibkia, K. (2014). Antimicrobial activity of the metals and metal oxide nanoparticles. Materials Science and Engineering: C, 44, 278–284.

https://doi.org/10.1517/17425247.2015.1049530

Ahmad, T., Wani, I. A., Lone, I. H., Ganguly, A., Manik, S., & Ahmad, A. (2013). Antifungal activity of gold nanoparticles prepared by solvothermal method. Materials Research Bulletin, 48(1), 12–20.

https://doi.org/10.1016/j.materresbull.2012.09.069

Li, Q., Mahendra, S., Lyon, D. Y., Brunet, L., Liga, M. V., Li, D., & Alvarez, P. J. (2008). Antimicrobial nanomaterials for water disinfection and microbial control: Potential applications and implications. Water Research, 42(18), 4591–4602.

https://doi.org/10.1016/j.watres.2008.08.015

Raghupathi, K. R., Koodali, R. T., & Manna, A. C. (2011). Size-dependent bacterial growth inhibition and mechanism of antibacterial activity of zinc oxide nanoparticles. Langmuir, 27(7), 4020–4028.

https://doi.org/10.1021/la104825u

Martinez-Gutierrez, F., Olive, P. L., Banuelos, A., Orrantia, E., Nino, N., Sanchez, E. M., ... & Ruiz, F. (2010). Synthesis, characterization, and evaluation of antimicrobial and cytotoxic effect of silver and titanium nanoparticles. Nanomedicine: Nanotechnology, Biology and Medicine, 6(5), 681–688.

https://doi.org/10.1016/j.nano.2010.02.001

Lemire, J. A., Harrison, J. J., & Turner, R. J. (2013). Antimicrobial activity of metals: Mechanisms, molecular targets and applications. Nature Reviews Microbiology, 11(6), 371–384.

https://doi.org/10.1038/nrmicro3028

Galdiero, S., Falanga, A., Vitiello, M., Cantisani, M., Marra, V., & Galdiero, M. (2011). Silver nanoparticles as potential antiviral agents. Molecules, 16(10), 8894–8918.

https://doi.org/10.3390/molecules16108894

Klaus, T., Joerger, R., Olsson, E., & Granqvist, C. G. (1999). Silver-based crystalline nanoparticles, microbially fabricated. Proceedings of the National Academy of Sciences, 96(24), 13611–13614.

https://doi.org/10.1073/pnas.96.24.13611

De Windt, W., Aelterman, P., & Verstraete, W. (2005). Bioreductive deposition of palladium (0) nanoparticles on Shewanella oneidensis with catalytic activity towards reductive dechlorination. Environmental Microbiology, 7(3), 314–325.

Mukherjee, P., Ahmad, A., Mandal, D., Senapati, S., Sainkar, S. R., Khan, M. I., ... & Sastry, M. (2001). Fungus-mediated synthesis of silver nanoparticles and their immobilization in the mycelial matrix: A novel biological approach to nanoparticle synthesis. Nano Letters, 1(10), 515–519.

https://doi.org/10.1021/nl0155274

Gholami-Shabani, M., Shams-Ghahfarokhi, M., & Razzaghi-Abyaneh, M. (2016). Biosynthesis of nanoparticles by fungi: Applications in biotechnology. Mycology, 7(2), 81–89.

https://doi.org/10.1007/978-981-10-8666-3_4

Annamalai, J., & Nallamuthu, T. (2016). Green synthesis of silver nanoparticles: Characterization and determination of antibacterial activity. Applied Nanoscience, 6(2), 259–265.

https://doi.org/10.1007/s13204-015-0426-6

Ahmed, S., Ahmad, M., Swami, B. L., & Ikram, S. (2016). A review on plants extract mediated synthesis of silver nanoparticles for antimicrobial applications: A green expertise. Journal of Advanced Research, 7(1), 17–28.

https://doi.org/10.1016/j.jare.2015.02.007

Singh, P., Kim, Y. J., Zhang, D., & Yang, D. C. (2016). Biological synthesis of nanoparticles from plants and microorganisms. Trends in Biotechnology, 34(7), 588–599.

https://doi.org/10.1016/j.tibtech.2016.02.006

Liu, J., & Jiang, X. (2015). Advances in nanoparticle-based drug delivery for bacterial infections. Current Opinion in Microbiology, 27, 86–93.

Pandey, R., & Khuller, G. K. (2005). Antitubercular inhaled therapy: Opportunities, progress and challenges. Journal of Antimicrobial Chemotherapy, 55(4), 430–435.

https://doi.org/10.1093/jac/dki027

Vallet-Regí, M., Balas, F., & Arcos, D. (2008). Mesoporous materials for drug delivery. Angewandte Chemie International Edition, 47(5), 7548–7558.

https://doi.org/10.1002/anie.200604488

Li, P., Li, J., Wu, C., Wu, Q., & Li, J. (2005). Synergistic antibacterial effects of β-lactam antibiotic combined with silver nanoparticles. Nanotechnology, 16(9), 1912–1917.

https://doi.org/10.1088/0957-4484/16/9/082

Mu, H., Guo, F., Niu, H., Liu, Y., Zhang, S., & Wang, Y. (2014). Chitosan nanoparticles for enhanced drug delivery to biofilms. Colloids and Surfaces B: Biointerfaces, 117, 203–209.

Hetrick, E. M., Shin, J. H., Paul, H. S., & Schoenfisch, M. H. (2009). Anti-biofilm efficacy of nitric oxide-releasing silica nanoparticles. Biomaterials, 30(14), 2782–2789.

https://doi.org/10.1016/j.biomaterials.2009.01.052

Jeremiah, S. S., Miyakawa, K., Morita, T., Yamaoka, Y., & Ryo, A. (2020). Potent antiviral effect of silver nanoparticles on SARS-CoV-2. Biochemical and Biophysical Research Communications, 533(1), 195–200.

https://doi.org/10.1016/j.bbrc.2020.09.018

Kim, J., Yeom, M., Lee, J., & Shin, H. (2011). Amphotericin B-loaded polymeric nanoparticles for antifungal therapy. Journal of Controlled Release, 152(Suppl 1), e133–e134.

Innocenzi, P., & Stagi, L. (2020). Graphene-based materials for antimicrobial applications. Applied Sciences, 10(17), 5977.

https://doi.org/10.1039/d0sc02658a

Augustine, R., Kalarikkal, N., & Thomas, S. (2014). Role of wound dressing in the management of chronic wounds: A review. Journal of Alloys and Compounds, 614, 343–351.

Sawai, J. (2003). Quantitative evaluation of antibacterial activities of metallic oxide powders (ZnO, MgO and CaO) by conductimetric assay. Journal of Microbiological Methods, 54(2), 177–182.

https://doi.org/10.1016/s0167-7012(03)00037-x

World Health Organization. (2021). Global tuberculosis report 2021. WHO Press.

Torres, A., Peetermans, W. E., Viegi, G., & Blasi, F. (2013). Risk factors for community-acquired pneumonia in adults in Europe: A literature review. Thorax, 68(11), 1057–1065.

https://doi.org/10.1136/thoraxjnl-2013-204282

Dube, A., Reynolds, J. L., Law, W. C., Maponga, C. C., Prasad, P. N., & Morse, G. D. (2014). Multimodal nanoparticles that provide immunoprotection and intracellular drug delivery for infectious diseases. Nanomedicine: Nanotechnology, Biology and Medicine, 10(4), 831–838.

Singh, R., Nawale, L., Arkile, M., Wadhwani, P., Shedbalkar, U., Chopade, B., ... & Vidyasagar, P. (2016). Silver nanoparticles: A novel antimycobacterial agent against Mycobacterium tuberculosis. Nanotechnology, 27(8), 085107.

https://doi.org/10.1016/j.ijantimicag.2015.03.014

Chuan, J., Li, Y., Yang, L., Sun, X., Zhang, Q., Gong, T., & Zhang, Z. (2013). Enhanced rifampicin delivery to alveolar macrophages by liposome encapsulation. International Journal of Pharmaceutics, 448(1), 135–141.

Jiang, J., Pi, J., & Cai, J. (2018). Zinc oxide nanoparticles for the treatment of bacterial infections. Frontiers in Microbiology, 9, 2709.

https://doi.org/10.1155/2018/1062562

Brown, A. N., Smith, K., Samuels, T. A., Lu, J., Obare, S. O., & Scott, M. E. (2012). Nanoparticles functionalized with ampicillin destroy multiple-antibiotic-resistant isolates of Pseudomonas aeruginosa and Enterobacter aerogenes and methicillin-resistant Staphylococcus aureus. Applied and Environmental Microbiology, 78(8), 2768–2774.

Ahmadi, A., Ahmadi, P., Ehsani, A., & Mahmoudi, M. (2020). Copper oxide nanoparticles as an effective anti-biofilm agent against Klebsiella pneumoniae. Journal of Medical Microbiology, 69(6), 831–837.

Shariati, A., Hosseini, S. M., Chegini, Z., Seifalian, A., & Arabestani, M. R. (2020). Chitosan-based nanoparticles for the treatment of bacterial infections. International Journal of Biological Macromolecules, 165(Pt A), 1392–1402.

https://doi.org/10.1016/j.biopha.2022.114184

Qais, F. A., Shafiq, A., Khan, H. M., Husain, F. M., Khan, R. A., Alenazi, B., ... & Ahmad, I. (2019). Antibacterial effect of silver nanoparticles synthesized using Murraya koenigii against Proteus mirabilis. Nanomaterials, 9(3), 441.

https://doi.org/10.1155/2019/4649506

Wang, Y., Zhang, L., Wang, X., & Zhang, Y. (2021). Selenium nanoparticles as a new strategy to combat Escherichia coli-induced urinary tract infections. Journal of Nanobiotechnology, 19(1), 112.

Rai, M., Yadav, A., & Gade, A. (2009). Silver nanoparticles as a new generation of antimicrobials. Biotechnology Advances, 27(1), 76–83.

https://doi.org/10.1016/j.biotechadv.2008.09.002

Gu, H., Ho, P. L., Tong, E., Wang, L., & Xu, B. (2003). Presenting vancomycin on nanoparticles to enhance antimicrobial activities. Nano Letters, 3(9), 1261–1263.

https://doi.org/10.1021/nl034396z

Jesline, A., John, N. P., Narayanan, P. M., Vani, C., & Murugan, S. (2015). Antimicrobial activity of zinc and titanium dioxide nanoparticles against biofilm-producing methicillin-resistant Staphylococcus aureus. Applied Nanoscience, 5(2), 157–162.

https://doi.org/10.1007/s13204-014-0301-x

Yausheva, E., Sizova, E., Lebedev, S., Skalny, A., & Miroshnikov, S. (2020). Effects of silver nanoparticles on the gut microbiota of rats. Nanomaterials, 10(7), 1351.

https://doi.org/10.1007/s11356-016-6474-y

Pietroiusti, A., Magrini, A., & Campagnolo, L. (2016). New frontiers in nanotoxicology: Gut microbiota/microbiome-mediated effects of engineered nanomaterials. Toxicology and Applied Pharmacology, 299, 90–95.

https://doi.org/10.1016/j.taap.2015.12.017

Lewinski, N., Colvin, V., & Drezek, R. (2008). Cytotoxicity of nanoparticles. Small, 4(1), 26–49.

https://doi.org/10.1002/smll.200700595

Angsantikul, P., Thamphiwatana, S., Zhang, Q., Spiekermann, K., Zhuang, J., Fang, R. H., ... & Zhang, L. (2018). Coating nanoparticles with gastric epithelial cell membrane for targeted antibiotic delivery against Helicobacter pylori infection. Advanced Therapeutics, 1(2), 1800016.

https://doi.org/10.1002/adtp.201800016

Lee, N.-Y., Ko, W.-C., & Hsueh, P.-R. (2019). Nanoparticles in the treatment of infections caused by multidrug-resistant organisms. Frontiers in Pharmacology, 10, 1153.

https://doi.org/10.3389/fphar.2019.01153